Dhampur Bio Organics President Harmeet Singh resigns
Dhampur Bio Organics (DBOL) said Harmeet Singh, President, has resigned. The company is valued at about ₹779 crore.
What happened
Dhampur Bio Organics (DBOL) told the exchanges on 31 October 2026 at 09:13 PM that Harmeet Singh, President, has resigned.
From the filing: "Harmeet Singh, Vice President - Financial Planning and Analysis, has tendered his resignation."
Company snapshot
Dhampur Bio Organics is a micro-cap company, with a market value of about ₹779 crore.
The stock last traded at ₹117.4, against a 52-week range of ₹69–₹151.8 (22.7% below the high).
Before this filing the shares had moved −5.7% over the month and +19.9% over three months. Average daily turnover over the last 20 sessions was about ₹5.23 crore.
Promoters held 50.78% at the end of Q1 FY27, up 0.13% points from the previous quarter. Foreign institutions owned 0.29% and domestic institutions 0.82%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 784 | -22 | -3.31 |
| Q2 FY26 | 825 | -16 | -2.41 |
| Q3 FY26 | 751 | 16.9 | 2.56 |
| Q4 FY26 | 774 | 46.3 | 7.01 |
| Q1 FY27 | 919 | 36.8 | 5.59 |
What history shows
This is not the company's first management change disclosure: BCEIE has 11 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 4.6% on average the next trading day and was up 8.3% on average after five days (8 filings with price data).
Market-wide, 4,080 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 22 Oct 2026 | Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we… | −6.3% | — |
| 1 Oct 2026 | Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, you are… | +14.1% | +22.0% |
| 1 Oct 2026 | Change in Designation of Mr Pankaj Agarwal as Vice President -… | +14.1% | +22.0% |
| 31 Jul 2026 | Management change | +10.5% | +19.2% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
- Dhampur Bio Organics to enter mycoprotein business using sugar and molasses as feedstock
- India’s Dhampur Bio Organics Signs Exclusive Mycoprotein Production Deal with Planetary
- Dhampur Bio Organics Licenses Planetary’s BioBlocks to Produce Mycoprotein in India
- Dhampur Bio Organics Enters Technology Licensing Agreement With Planetary
- Dhampur Bio signs exclusive mycoprotein licensing deal with Planetary SA
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.